Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Contract Manufacture Organization (CMO) Market by Type (Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)), By Application (Pharmaceutical Industry, Biotechnology, Medical Device Industry) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Contract Manufacture Organization (CMO) Market by Type (Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)), By Application (Pharmaceutical Industry, Biotechnology, Medical Device Industry) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 302646 4200 Service & Software 377 236 Pages 4.5 (48)
                                          

Industry Growth Insights published a new data on “Contract Manufacture Organization (CMO) Market”. The research report is titled “Contract Manufacture Organization (CMO) Market research by Types (Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)), By Applications (Pharmaceutical Industry, Biotechnology, Medical Device Industry), By Players/Companies Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Contract Manufacture Organization (CMO) Market Research Report

By Type

Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)

By Application

Pharmaceutical Industry, Biotechnology, Medical Device Industry

By Companies

Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

236

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Contract Manufacture Organization (CMO) Industry Outlook


Global Contract Manufacture Organization (CMO) Market Report Segments:

The global Contract Manufacture Organization (CMO) market is segmented on the basis of:

Types

Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical Industry, Biotechnology, Medical Device Industry

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Lonza
  2. Boehringer Ingelheim
  3. Catalent
  4. Baxter
  5. AbbVie
  6. Pfizer
  7. Evonik
  8. Fareva group
  9. Aenova
  10. Almac
  11. Delpharm
  12. Recipharm
  13. Aesica
  14. NIPRO CORPORATION
  15. Daito Pharmaceutical
  16. Teva API
  17. Esteve Quimica
  18. Euticals
  19. Zhejiang Hisun Pharmaceuticals

Global Contract Manufacture Organization (CMO) Market Overview


Highlights of The Contract Manufacture Organization (CMO) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Active Pharmaceutical Ingredients (APIs)
    2. Finished Dose Formulations (FDFs)
  1. By Application:

    1. Pharmaceutical Industry
    2. Biotechnology
    3. Medical Device Industry
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Contract Manufacture Organization (CMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Contract Manufacture Organization (CMO) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A Contract Manufacture Organization (CMO) is a business model in which a company contracts with other companies to produce products or services. The contract manufacturer typically assembles the products or performs the services, but sometimes outsources certain components or tasks. The CMO can be an effective way to reduce costs and increase efficiency by leveraging economies of scale and specialization.

Some of the major companies in the contract manufacture organization (cmo) market are Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Manufacture Organization (CMO) Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Contract Manufacture Organization (CMO) Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Contract Manufacture Organization (CMO) Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Contract Manufacture Organization (CMO) Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Contract Manufacture Organization (CMO) Market Size & Forecast, 2018-2028       4.5.1 Contract Manufacture Organization (CMO) Market Size and Y-o-Y Growth       4.5.2 Contract Manufacture Organization (CMO) Market Absolute $ Opportunity

Chapter 5 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Contract Manufacture Organization (CMO) Market Size Forecast by Type
      5.2.1 Active Pharmaceutical Ingredients (APIs)
      5.2.2 Finished Dose Formulations (FDFs)
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      6.2.1 Pharmaceutical Industry
      6.2.2 Biotechnology
      6.2.3 Medical Device Industry
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Contract Manufacture Organization (CMO) Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Contract Manufacture Organization (CMO) Analysis and Forecast
   9.1 Introduction
   9.2 North America Contract Manufacture Organization (CMO) Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Contract Manufacture Organization (CMO) Market Size Forecast by Type
      9.6.1 Active Pharmaceutical Ingredients (APIs)
      9.6.2 Finished Dose Formulations (FDFs)
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      9.10.1 Pharmaceutical Industry
      9.10.2 Biotechnology
      9.10.3 Medical Device Industry
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Contract Manufacture Organization (CMO) Analysis and Forecast
   10.1 Introduction
   10.2 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Type
      10.6.1 Active Pharmaceutical Ingredients (APIs)
      10.6.2 Finished Dose Formulations (FDFs)
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      10.10.1 Pharmaceutical Industry
      10.10.2 Biotechnology
      10.10.3 Medical Device Industry
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Contract Manufacture Organization (CMO) Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Type
      11.6.1 Active Pharmaceutical Ingredients (APIs)
      11.6.2 Finished Dose Formulations (FDFs)
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      11.10.1 Pharmaceutical Industry
      11.10.2 Biotechnology
      11.10.3 Medical Device Industry
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Contract Manufacture Organization (CMO) Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Type
      12.6.1 Active Pharmaceutical Ingredients (APIs)
      12.6.2 Finished Dose Formulations (FDFs)
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      12.10.1 Pharmaceutical Industry
      12.10.2 Biotechnology
      12.10.3 Medical Device Industry
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Type
      13.6.1 Active Pharmaceutical Ingredients (APIs)
      13.6.2 Finished Dose Formulations (FDFs)
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Applications
      13.10.1 Pharmaceutical Industry
      13.10.2 Biotechnology
      13.10.3 Medical Device Industry
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Contract Manufacture Organization (CMO) Market: Competitive Dashboard
   14.2 Global Contract Manufacture Organization (CMO) Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 Lonza
      14.3.2 Boehringer Ingelheim
      14.3.3 Catalent
      14.3.4 Baxter
      14.3.5 AbbVie
      14.3.6 Pfizer
      14.3.7 Evonik
      14.3.8 Fareva group
      14.3.9 Aenova
      14.3.10 Almac
      14.3.11 Delpharm
      14.3.12 Recipharm
      14.3.13 Aesica
      14.3.14 NIPRO CORPORATION
      14.3.15 Daito Pharmaceutical
      14.3.16 Teva API
      14.3.17 Esteve Quimica
      14.3.18 Euticals
      14.3.19 Zhejiang Hisun Pharmaceuticals

Our Trusted Clients

Contact Us